ALK and neoplasm: The release of GzB into the cytosol would be predicted to be particularly detrimental in ALK+ ALCL, as tumour cells in ALK+ ALCL patient samples do not express the GzB inhibitor, proteinase inhibitor-9 (PI-9) [28].